Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc > if this PP has ticotime2020 and northernman in it

<< Previous

Bullboard Posts

Next >>

Comment by Firepokeron Apr 10, 2024 9:00pm

82 Views

Post# 35982480

RE:if this PP has ticotime2020 and northernman in it

"the Offering will be funded solely by a small group of long-term shareholders, known to the Company, who have expressed commitments."

Tico said no...but appears to be in the know. ..and pleased with the outcome..

Company is paying someone a "finders fee"...for these longterm "committed" shareholder's...

Interesting turn of events...a bit greasy maybe.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant